 | • レポートコード：MRC309Z7758 • 出版社/出版日：GlobalInfoResearch / 2023年9月20日 • レポート形態：英文、PDF、79ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界の5-in-1 DTaP-Hib-IPVワクチンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界の5-in-1 DTaP-Hib-IPVワクチン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - 5-in-1 DTaP-Hib-IPVワクチンの成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため 5-in-1 DTaP-Hib-IPVワクチン市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・8ヶ月、18ヶ月 用途別セグメント ・病院、コミュニティ 主要な市場プレーヤー ・Sanofi Pasteur 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、5-in-1 DTaP-Hib-IPVワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な5-in-1 DTaP-Hib-IPVワクチンメーカーの企業概要、2019年～2022年までの5-in-1 DTaP-Hib-IPVワクチンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な5-in-1 DTaP-Hib-IPVワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別5-in-1 DTaP-Hib-IPVワクチンの販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までの5-in-1 DTaP-Hib-IPVワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での5-in-1 DTaP-Hib-IPVワクチン市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、および5-in-1 DTaP-Hib-IPVワクチンの産業チェーンを掲載しています。 ・第14、15章では、5-in-1 DTaP-Hib-IPVワクチンの販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - 5-in-1 DTaP-Hib-IPVワクチンの概要 - 種類別分析（2018年vs2022年vs2029年）：8ヶ月、18ヶ月 - 用途別分析（2018年vs2022年vs2029年）：病院、コミュニティ - 世界の5-in-1 DTaP-Hib-IPVワクチン市場規模・予測 - 世界の5-in-1 DTaP-Hib-IPVワクチン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Sanofi Pasteur ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：8ヶ月、18ヶ月 ・用途別分析2018年-2029年：病院、コミュニティ ・5-in-1 DTaP-Hib-IPVワクチンの北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・5-in-1 DTaP-Hib-IPVワクチンのヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・5-in-1 DTaP-Hib-IPVワクチンのアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・5-in-1 DTaP-Hib-IPVワクチンの南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・5-in-1 DTaP-Hib-IPVワクチンの中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global 5-in-1 DTaP-Hib-IPV Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
A 5-in-1 DTaP-Hib-IPV vaccine is an inactivated one that is injected to simultaneously protect against five infectious diseases: diphtheria, tetanus, pertussis, poliomyelitis and haemophilus influenzae type b.
The Global Info Research report includes an overview of the development of the 5-in-1 DTaP-Hib-IPV Vaccine industry chain, the market status of Hospital (8-month, 18-month), Community (8-month, 18-month), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of 5-in-1 DTaP-Hib-IPV Vaccine.
Regionally, the report analyzes the 5-in-1 DTaP-Hib-IPV Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global 5-in-1 DTaP-Hib-IPV Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the 5-in-1 DTaP-Hib-IPV Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the 5-in-1 DTaP-Hib-IPV Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., 8-month, 18-month).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the 5-in-1 DTaP-Hib-IPV Vaccine market.
Regional Analysis: The report involves examining the 5-in-1 DTaP-Hib-IPV Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the 5-in-1 DTaP-Hib-IPV Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to 5-in-1 DTaP-Hib-IPV Vaccine:
Company Analysis: Report covers individual 5-in-1 DTaP-Hib-IPV Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards 5-in-1 DTaP-Hib-IPV Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Community).
Technology Analysis: Report covers specific technologies relevant to 5-in-1 DTaP-Hib-IPV Vaccine. It assesses the current state, advancements, and potential future developments in 5-in-1 DTaP-Hib-IPV Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the 5-in-1 DTaP-Hib-IPV Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
5-in-1 DTaP-Hib-IPV Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
8-month
18-month
Market segment by Application
Hospital
Community
Major players covered
Sanofi Pasteur
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe 5-in-1 DTaP-Hib-IPV Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of 5-in-1 DTaP-Hib-IPV Vaccine, with price, sales, revenue and global market share of 5-in-1 DTaP-Hib-IPV Vaccine from 2018 to 2023.
Chapter 3, the 5-in-1 DTaP-Hib-IPV Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the 5-in-1 DTaP-Hib-IPV Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and 5-in-1 DTaP-Hib-IPV Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of 5-in-1 DTaP-Hib-IPV Vaccine.
Chapter 14 and 15, to describe 5-in-1 DTaP-Hib-IPV Vaccine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of 5-in-1 DTaP-Hib-IPV Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 8-month
1.3.3 18-month
1.4 Market Analysis by Application
1.4.1 Overview: Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Community
1.5 Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size & Forecast
1.5.1 Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity (2018-2029)
1.5.3 Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur 5-in-1 DTaP-Hib-IPV Vaccine Product and Services
2.1.4 Sanofi Pasteur 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Pasteur Recent Developments/Updates
3 Competitive Environment: 5-in-1 DTaP-Hib-IPV Vaccine by Manufacturer
3.1 Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global 5-in-1 DTaP-Hib-IPV Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of 5-in-1 DTaP-Hib-IPV Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 5-in-1 DTaP-Hib-IPV Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 5-in-1 DTaP-Hib-IPV Vaccine Manufacturer Market Share in 2022
3.5 5-in-1 DTaP-Hib-IPV Vaccine Market: Overall Company Footprint Analysis
3.5.1 5-in-1 DTaP-Hib-IPV Vaccine Market: Region Footprint
3.5.2 5-in-1 DTaP-Hib-IPV Vaccine Market: Company Product Type Footprint
3.5.3 5-in-1 DTaP-Hib-IPV Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size by Region
4.1.1 Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Region (2018-2029)
4.2 North America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029)
4.3 Europe 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029)
4.5 South America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2029)
5.2 Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Type (2018-2029)
5.3 Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2029)
6.2 Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Application (2018-2029)
6.3 Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2029)
7.2 North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2029)
7.3 North America 5-in-1 DTaP-Hib-IPV Vaccine Market Size by Country
7.3.1 North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe 5-in-1 DTaP-Hib-IPV Vaccine Market Size by Country
8.3.1 Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Market Size by Region
9.3.1 Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2029)
10.2 South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2029)
10.3 South America 5-in-1 DTaP-Hib-IPV Vaccine Market Size by Country
10.3.1 South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Market Size by Country
11.3.1 Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 5-in-1 DTaP-Hib-IPV Vaccine Market Drivers
12.2 5-in-1 DTaP-Hib-IPV Vaccine Market Restraints
12.3 5-in-1 DTaP-Hib-IPV Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of 5-in-1 DTaP-Hib-IPV Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of 5-in-1 DTaP-Hib-IPV Vaccine
13.3 5-in-1 DTaP-Hib-IPV Vaccine Production Process
13.4 5-in-1 DTaP-Hib-IPV Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 5-in-1 DTaP-Hib-IPV Vaccine Typical Distributors
14.3 5-in-1 DTaP-Hib-IPV Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer